Sanjeevan Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.21 M
as on 17-07-2024
- Company Age 24 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
as on 17-07-2024
- Revenue -11.39%
(FY 2023)
- Profit 441.32%
(FY 2023)
- Ebitda 76.33%
(FY 2023)
- Net Worth 2.82%
(FY 2023)
- Total Assets 21.10%
(FY 2023)
About Sanjeevan Drugs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.21 M.
The company currently has active open charges totaling ₹4.00 M.
Anita Aggarwal and Meghna Singhania serve as directors at the Company.
- CIN/LLPIN
U33119DL2000PTC107325
- Company No.
107325
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sanjeevan Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anita Aggarwal  | Director | 17-Aug-2000 | Current |
| Meghna Singhania | Director | 02-May-2011 | Current |
Financial Performance of Sanjeevan Drugs.
Sanjeevan Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.39% decrease. The company also saw a substantial improvement in profitability, with a 441.32% increase in profit. The company's net worth moved up by a moderate rise of 2.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjeevan Drugs?
In 2023, Sanjeevan Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Minerva Medical Treatment Private LimitedActive 13 years 10 monthsAnita Aggarwal and Meghna Singhania are mutual person
Sanjeevan Medical Research Centre Private LimitedActive 42 years 5 monthsAnita Aggarwal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahbad Bank Creation Date: 29 Sep 2011 | ₹4.00 M | Open |
How Many Employees Work at Sanjeevan Drugs?
Unlock and access historical data on people associated with Sanjeevan Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjeevan Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjeevan Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
